Chun-Xi Wang

Chun-Xi Wang


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Biomaterials
Verified
Journal Article
Closed access
KZKaidong Zhao
Kaidong Zhao
DLDi Li
Di Li
WXWeiguo Xu
Weiguo Xu
Jianxun DingJianxun Ding
Jianxun Ding
WJWeiqian Jiang
Weiqian Jiang
XCXuesi Chen
Xuesi Chen

1 February 2015 in Journal of Urology
Verified
Journal Article
Closed access
JLJi Lu
Ji Lu
PLPeter E. Lonergan
Peter E. Lonergan
LNLucas P. Nacusi
Lucas P. Nacusi
LWLiguo Wang
Liguo Wang
LSLucy J. Schmidt
Lucy J. Schmidt
DTDonald J. Tindall
Donald J. Tindall
Spliced variant forms of androgen receptor were recently identified in castration resistant prostate cancer cell lines and clinical samples. We identified the cistrome and gene signature of androgen receptor splice variants in castration resistant prostate cancer cell lines and determined the clinical significance of androgen receptor splice variant regulated genes. The castration resistant prostate cancer cell line 22Rv1, which expresses full-length androgen receptor and androgen receptor splice variants endogenously, was used as the research model. We established 22Rv1-ARFL(-)/ARV(+) and 22Rv1-ARFL(-)/ARV(-) through RNA interference. Chromatin immunoprecipitation coupled with next generation sequencing and microarray techniques were used to identify the cistrome and gene expression profiles of androgen receptor splice variants in the absence of androgen. Androgen receptor splice variant binding sites were identified in 22Rv1-ARFL(-)/ARV(+). A gene set was regulated uniquely by androgen receptor splice variants but not by full-length androgen receptor in the absence of androgen. Integrated analysis revealed that some genes were directly modulated by androgen receptor splice variants. Unsupervised clustering analysis showed that the androgen receptor splice variant gene signature differentiated benign from malignant prostate tissue as well as localized prostate cancer from metastatic castration resistant prostate cancer specimens. Some genes that were modulated uniquely by androgen receptor splice variants also correlated with histological grade and biochemical failure. Androgen receptor splice variants can bind to DNA independent of full-length androgen receptor in the absence of androgen and modulate a unique set of genes that is not regulated by full-length androgen receptor. The androgen receptor splice variant gene signature correlates with disease progression. It distinguishes primary cancer from castration resistant prostate cancer specimens and benign from malignant prostate specimens.

9 February 2013 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
YWYong Wang
Yong Wang
RZRui Zhang
Rui Zhang
DWDonglu Wu
Donglu Wu
ZLZhihua Lu
Zhihua Lu
WSWentao Sun
Wentao Sun
JJJingji Jin
Jingji Jin
MYST1 (also known as hMOF), a member of the MYST family of histone acetyltransferases (HATs) as an epigenetic mark of active genes, is mainly responsible for histone H4K16 acetylation in the cells. Recent studies have shown that the abnormal gene expression of hMOF is involved in certain primary cancers. Here we examined the involvement of hMOF expression and histone H4K16 acetylation in primary renal cell carcinoma (RCC). Simultaneously, we investigated the correlation between the expression of hMOF and clear cell RCC (ccRCC) biomarker carbohydrase IX (CA9) in RCC.

13 March 2020 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
HGHui Guo
Hui Guo
FLFaping Li
Faping Li
HQHeping Qiu
Heping Qiu
JLJianhua Liu
Jianhua Liu
SQSihao Qin
Sihao Qin
CWChun-Xi Wang
Chun-Xi Wang
The poor solubility and permeability of most chemotherapeutic drugs lead to unsatisfactory bioavailability combined with insufficient drug concentration. In this study, positively charged nanoparticles based on chitosan were developed and synthesized to enhance tumor penetration capability of 10-Hydroxycamptothecin (HCPT) in order to improve the chemotherapeutic effect of melanoma. The HCPT encapsulated nanoparticles were noted as NPs/HCPT. NPs/HCPT was characterized by dynamic light scattering and zeta potential measurements. In addition, cell uptake, in vitro cytotoxicity, apoptosis and in vivo antitumor activity of NPs/HCPT were further investigated. The average diameter of NPs/HCPT was approximately 114.6 ± 4.1 nm. The viability of murine melanoma cell lines (B16F10 and B16F1) was significantly decreased due to interaction with NPs/HCPT. Moreover, NPs/HCPT significantly inhibited the progression of tumors. These investigations implied that cationic NPs/HCPT could be potentially applied as a promising drug delivery nanosystem.

26 February 2014 in Cell Proliferation
Verified
Journal Article
Closed access
PDF file
XDX. Ding
X. Ding
YWY. Wang
Y. Wang
XMX. Ma
X. Ma
HGH. Guo
H. Guo
XYX. Yan
X. Yan
CWChun-Xi Wang
Chun-Xi Wang

1 January 2013 in International Journal of Medical Sciences
Verified
Journal Article
Open access
YWYanbo Wang
Yanbo Wang
YWYan Wang
Yan Wang
YYYunming Yao
Yunming Yao
NXNing Xu
Ning Xu
HZHaifeng Zhang
Haifeng Zhang
CWChun-Xi Wang
Chun-Xi Wang
Objective: To perform a prospective randomized trial comparing the efficacy and safety of percutaneous nephrolithotomy (PCNL) in the prone and modified supine positions.